Filing Details

Accession Number:
0001415889-25-012096
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-06 16:05:06
Reporting Period:
2025-05-02
Filing Date:
2025-05-06
Accepted Time:
2025-05-06 16:05:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1811063 Nuvation Bio Inc. NUVB Pharmaceutical Preparations (2834) 850862255
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1937915 Dongfang Liu C/O Nuvation Bio Inc.
1500 Broadway, Suite 401
New York NY 10036
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2025-05-02 20,000 $1.94 32,000 No 4 M Direct
Class A Common Stock Disposition 2025-05-02 20,000 $2.50 12,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (Right to Buy) Disposition 2025-05-02 20,000 $1.94 20,000 $1.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
480,000 2033-02-27 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan dated October 10, 2024.
  2. Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.50 to $2.505. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. Option vests as to 25% on 2/28/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date